Target intelligence / Profile preview

ribosomal protein L7a pseudogene 29 (RPL7AP29)

Target
RPL7AP29
Molecular classification
Other (pseudogene; not a member of canonical receptor, enzyme, transporter, or other druggable protein families)[2][5]
01

Overview

RPL7AP29 (ribosomal protein L7a pseudogene 29) is a processed pseudogene found in the human genome, related in sequence to the ribosomal protein L7a gene (RPL7A)[2][5]. Unlike functional ribosomal protein genes, RPL7AP29 does not encode a functional ribosomal protein and is not involved in the biogenesis or function of ribosomes. Pseudogenes such as RPL7AP29 have historically accumulated in the genome due to duplication or retrotransposition events but do not produce active proteins and have no documented roles as therapeutic targets, disease mechanisms, or biomarkers[2][5][8]. RPL7AP29 is distinct from the functional RPL7A gene product, which is a component of the large (60S) ribosomal subunit and plays roles in ribosomal function and protein synthesis[1][6][7]. **Key distinction:** RPL7AP29 is a **pseudogene**—not a functional protein target—and there is nothing to suggest it is misspelled, but it is *not* actionable for therapeutic intervention, drug discovery, or biomarker selection[2][5][8].

Other names
RPL7AP29RPL7A_7_455Ribosomal protein L7a pseudogene 29[2][5][8]
02

Biological functions

Other (does not encode a functional protein; therefore, no known biological function)[2][5]
03

Disease associations

Other (no documented disease associations; not known to play a role in disease)[2]

Beyond the preview

Go deeper on ribosomal protein L7a pseudogene 29 (RPL7AP29).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ribosomal protein L7a pseudogene 29 (RPL7AP29).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call